Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
About Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Institut de Recherches Internationales Servier
2
Clinical Trials at Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
During the past decade, Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
2011-03-31
2017-01-31
Completed
50
A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer
2011-08-12
2016-05-18
Completed
77
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
2014-08-19
2026-09-29
Active, not recruiting
303
A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)
2014-04-30
2016-06-10
Completed
172
Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
2016-05-01
2020-04-09
Completed
78
A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).
2016-10-18
2020-11-30
Completed
907
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica" are
"Non-Small Cell Lung Cancer" (3 trials), "Breast Cancer" (2 trials), "Metastatic Colorectal Cancer" (2 trials), "Colorectal Cancer" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
Most popular intervention types in "Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Oxaliplatin" (2 trials), "5-Fluorouracil (5-FU)" (1 trials), "Alectinib" (1 trials) and "Aromatase Inhibitor" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
The vast majority of trials in "Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica
Currently, there are NaN active trials in "Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".